血清淀粉样蛋白A、C反应蛋白与前白蛋白比值诊断慢性阻塞性肺疾病急性加重期合并下呼吸道感染的价值

石芳

石芳. 血清淀粉样蛋白A、C反应蛋白与前白蛋白比值诊断慢性阻塞性肺疾病急性加重期合并下呼吸道感染的价值[J]. 实用临床医药杂志, 2020, 24(19): 22-25. DOI: 10.7619/jcmp.202019007
引用本文: 石芳. 血清淀粉样蛋白A、C反应蛋白与前白蛋白比值诊断慢性阻塞性肺疾病急性加重期合并下呼吸道感染的价值[J]. 实用临床医药杂志, 2020, 24(19): 22-25. DOI: 10.7619/jcmp.202019007
SHI Fang. Values of serum amyloid A and ratio of C reactive protein to prealbumin in diagnosis of acute exacerbation of chronic obstructive pulmonary disease complicated with lower respiratory tract infection[J]. Journal of Clinical Medicine in Practice, 2020, 24(19): 22-25. DOI: 10.7619/jcmp.202019007
Citation: SHI Fang. Values of serum amyloid A and ratio of C reactive protein to prealbumin in diagnosis of acute exacerbation of chronic obstructive pulmonary disease complicated with lower respiratory tract infection[J]. Journal of Clinical Medicine in Practice, 2020, 24(19): 22-25. DOI: 10.7619/jcmp.202019007

血清淀粉样蛋白A、C反应蛋白与前白蛋白比值诊断慢性阻塞性肺疾病急性加重期合并下呼吸道感染的价值

基金项目: 

2017年湖北省卫生计生委科研立项项目(WJ2015MF289)

详细信息
  • 中图分类号: R441.8

Values of serum amyloid A and ratio of C reactive protein to prealbumin in diagnosis of acute exacerbation of chronic obstructive pulmonary disease complicated with lower respiratory tract infection

  • 摘要: 目的 分析血清淀粉样蛋白A(SAA)、C反应蛋白与前白蛋白比值(CRP/PA)早期诊断慢性阻塞性肺疾病急性加重期(AECOPD)合并下呼吸道感染的价值。 方法 选取AECOPD合并下呼吸道感染患者250例为AECOPD组,另选取正常体检人群100例为对照组。AECOPD组给予常规抗感染、止咳化痰、平喘及吸氧等治疗。比较2组生命体征指标(体温、心率、白细胞计数及中性粒细胞百分比)、实验室指标[SAA、C反应蛋白(CRP)、前白蛋白(PA)、CRP/PA]。采用受试者工作特征(ROC)曲线分析血清SAA、CRP/PA早期诊断AECOPD合并下呼吸道感染的价值。 结果 AECOPD组心率、白细胞计数及中性粒细胞百分比均高于对照组,差异有统计学意义(P<0.01)。治疗前, AECOPD组血清SAA、CRP、CRP/PA水平高于对照组, PA水平低于对照组,差异均有统计学意义(P<0.01); 治疗后, AECOPD组血清SAA、CRP、CRP/PA降低, PA水平升高,差异均有统计学意义(P<0.01)。ROC曲线分析结果显示, SAA、CRP/PA诊断AECOPD合并下呼吸道感染的曲线下面积(AUC)分别为0.829、0.862, 敏感性和特异性分别为84.54%、83.43%和79.87%、87.66%。 结论 血清SAA、CRP/PA可作为早期诊断AECOPD合并下呼吸道感染的有效生物标志物,均具有较高的敏感性和特异性。
  • WONG A W, GAN W Q, BURNS J, et al. Acute exacerbation of chronic obstructive pulmonary disease: influence of social factors in determining length of hospital stay and readmission rates[J]. Canadian Respiratory Journal, 2008, 15(7): 361-364.

    HWANG S L, LIN Y C, GUO S E, et al. Fine particulate matter on hospital admissions for acute exacerbation of chronic obstructive pulmonary disease in southwestern Taiwan during 2006-2012[J]. International Journal of Environmental Health Research, 2017, 27(2): 95-105.

    XU N, CHEN J, CHANG X, et al. nCD64 index as a prognostic biomarker for mortality in acute exacerbation of chronic obstructive pulmonary disease[J]. Annals of Saudi Medicine, 2016, 36(1): 37-41.

    LIU X R, LIU Y L, HUANG X Y, et al. Endothelial progenitor cell dysfunction in acute exacerbation of chronic obstructive pulmonary disease[J]. Molecular Medicine Reports, 2017, 16(4): 5294-5302.

    D E BUCK M, GOUWY M, WANG J M, et al. Structure and expression of different serum amyloid A(SAA)variants and their concentration-dependent functions during host insults[J]. Curr Med Chem, 2016, 23(17): 1725-1755.

    LI L, DAI L H, WANG X, et al. Predictive value of the C-reactive protein-to-prealbumin ratio in medical ICU patients[J]. Biomarkers in Medicine, 2017, 11(4): 329-337.

    中华医学会呼吸病学分会慢性阻塞性肺疾病学组. 慢性阻塞性肺疾病诊治指南(2013年修订版)[J]. 中华结核和呼吸杂志, 2013, 36(4): 255-264.

    LAI T, WU D, CHEN M, et al. YKL-40 expression in chronic obstructive pulmonary disease: relation to acute exacerbations and airway remodeling[J]. Respir Res, 2016, 17: 31-39.

    SHI L, ZHU B J, XU M L, et al. Selection of AECOPD-specific immunomodulatory biomarkers by integrating genomics and proteomics with clinical informatics[J]. Cell Biology and Toxicology, 2018, 34(2): 109-123.

    SONG Y L, CHEN W, CHEN R C, et al. The optimum timing to wean invasive ventilation for patients with AECOPD or COPD with pulmonary infection[J]. Int J Chronic Obstr Pulm Dis, 2016: 535-542.

    ZHANG J, CHANG C, SHEN N, et al. Systemic inflammatory marker CRP was better predictor of readmission for AECOPD than sputum inflammatory markers[J]. Archivos De Bronconeumologia, 2016, 52(3): 138-144.

    SUN L, YE R D. Serum amyloid A1: Structure, function and gene polymorphism[J]. Gene, 2016, 583(1): 48-57.

    DE BUCK M, GOUWY M, WANG J M, et al. The cytokine-serum amyloid A-chemokine network[J]. Cytokine Growth Factor Rev, 2016, 30: 55-69.

    XIE X, MA Y T, YANG Y N, et al. Genetic polymorphisms of serum amyloid A1 and coronary artery disease risk[J]. Tissue Antigens, 2015, 85(3): 168-176.

    AGNELLO L, BELLIA C, DI GANGI M, et al. Utility of serum procalcitonin and C-reactive protein in severity assessment of community-acquired pneumonia in children[J]. Clinical Biochemistry, 2016, 49(1/2): 47-50.

    CODULLO V, CEREDA E, KLERSY C, et al. Serum prealbumin is an independent predictor of mortality in systemic sclerosis outpatients[J]. Rheumatology(Oxford, England), 2016, 55(2): 315-319.

    YE S, LIN S P, WU K P, et al. Serum prealbumin is a predictive biomarker for stroke-associated infection after an ischemic stroke[J]. Int J Neurosci, 2017, 127(7): 601-605.

    D E MAGISTRIS L, PAQUETTE B, ORRY D, et al. Preoperative inflammation increases the risk of infection after elective colorectal surgery: results from a prospective cohort[J]. International Journal of Colorectal Disease, 2016, 31(9): 1611-1617.

计量
  • 文章访问数:  262
  • HTML全文浏览量:  42
  • PDF下载量:  8
  • 被引次数: 0
出版历程
  • 收稿日期:  2020-07-22

目录

    /

    返回文章
    返回
    x 关闭 永久关闭